RetinalGenix Technologies (RTGN) Common Equity (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Common Equity of -$2.6 million for Q1 2026, down 11.09% sequentially from -$2.3 million in Q4 2025, and down 53.37% YoY from -$5.5 million in Q1 2025.
RetinalGenix Technologies (RTGN) Common Equity (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Common Equity for 7 years, with the latest figure at -$2.6 million in Q1 2026.
- Quarterly Common Equity fell 53.37% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 53.37% YoY) and the FY2025 annual result came in at -$2.3 million, down 57.43% from the prior year.
- Common Equity declined to -$2.6 million in Q1 2026 per RTGN's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Common Equity peaked at -$675175.0 in Q2 2022 and troughed at -$2.6 million in Q1 2026.
- A 5-year average of -$1.6 million and a median of -$1.5 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2024: Common Equity sank 1789.02% in 2022, then decreased 1.17% in 2024.
- Over 5 years, Common Equity stood at -$1.1 million in 2022, then tumbled by 31.48% to -$1.4 million in 2023, then declined by 4.05% to -$1.5 million in 2024, then slumped by 57.43% to -$2.3 million in 2025, then declined by 11.09% to -$2.6 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered -$2.6 million, -$2.3 million, and -$2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 7.22 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.56 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -1.98 Mn |
| Mar 31, 2025 | -1.67 Mn |
| Dec 31, 2024 | -1.46 Mn |
| Sep 30, 2024 | -1.85 Mn |
| Jun 30, 2024 | -1.81 Mn |
| Mar 31, 2024 | -1.52 Mn |
| Dec 31, 2023 | -1.41 Mn |
| Sep 30, 2023 | -1.08 Mn |
| Jun 30, 2023 | -1.77 Mn |
| Mar 31, 2023 | -1.50 Mn |
| Dec 31, 2022 | -1.07 Mn |
| Sep 30, 2022 | -1.06 Mn |
| Jun 30, 2022 | -675,175.00 |
| Mar 31, 2022 | -724,323.00 |
| Dec 31, 2021 | -464,675.00 |
| Sep 30, 2021 | -412,708.00 |
| Jun 30, 2021 | -35,742.00 |